20250163092. Polymorphic (EFFEPHARM (SHANGHAI) ., .)
POLYMORPHIC FORM OF REDUCED BETA-NICOTINAMIDE MONONUCLEOTIDE DISODIUM SALT, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Abstract: a polymorph of a reduced �-nicotinamide mononucleotide disodium salt, and a preparation method therefor and the use thereof as a pharmaceutical ingredient, a healthcare product ingredient, a cosmetic ingredient, or a food additives, and a preparation containing the salts are provided. a polymorph of nmnh disodium salt has excellent solubility, stability, flow performance, and hygroscopicity resistance. its purification effects is better than that of amorphous forms.
Inventor(s): Xing GAO, Jianjun YU, Qiang SHEN, Qinyuan XU, Yinshan LI, Jialing LIU, Liulei CHANG
CPC Classification: C07H19/048 (SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids , ; aldonic acids, saccharic acids , ; cyanohydrins ; glycals ; compounds of unknown constitution ; polysaccharides, derivatives thereof ; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification ; sugar industry ))
Search for rejections for patent application number 20250163092